09/27/2021

Enrollment begins for Sanofi and GSK’s Phase 3 efficacy trial of COVID-19 vaccine candidate in Nepal, led by IVI

International Vaccine Institute (IVI) will lead the clinical trial in Nepal to assess the safety, efficacy and immunogenicity of an adjuvanted recombinant-protein COVID-19 vaccine candidate Phase 3 international clinical trial includes volunteers from several countries, including sites in the US, Asia, Africa and Latin America […]
09/28/2021

The International Vaccine Institute, Texas Children’s Hospital, and Baylor College of Medicine partner for collaborative vaccine research

Sept. 28, 2021 – SEOUL, South Korea, and HOUSTON, Texas, USA – The International Vaccine Institute (IVI), the Texas Children’s Hospital Center for Vaccine Development, and Baylor College of Medicine’s National School of Tropical Medicine signed a Memorandum of Understanding to promote and further academic […]
09/29/2021

South China Morning Post | Coronavirus: as rich countries turn to big-name booster shots from Pfizer, AstraZeneca, the poor are left with lesser-known rivals like Abdala, Soberana 2

09/30/2021

The New York Times | How Asia, Once a Vaccination Laggard, Is Revving Up Inoculations